These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10416484)

  • 1. [Roaming through the methodology. XIV. The premature ending of a randomized trial].
    Vandenbroucke JP
    Ned Tijdschr Geneeskd; 1999 Jun; 143(25):1305-8. PubMed ID: 10416484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stopping rules, interim analyses and data monitoring committees.
    Ashby D; Machin D
    Br J Cancer; 1993 Dec; 68(6):1047-50. PubMed ID: 8260354
    [No Abstract]   [Full Text] [Related]  

  • 3. [Roaming through methodology. IX. The interpretation of subgroup analyses].
    van der Windt DA; van Poppel MN
    Ned Tijdschr Geneeskd; 1998 Oct; 142(41):2245-7. PubMed ID: 9864501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethical issues in the substantive and procedural aspects of research ethics review.
    Meslin EM
    Health Law Can; 1993; 13(3):179-91. PubMed ID: 10125789
    [No Abstract]   [Full Text] [Related]  

  • 5. Is informed consent always necessary for randomized, controlled trials?
    Dresser R
    N Engl J Med; 1999 Aug; 341(6):449; author reply 450. PubMed ID: 10438261
    [No Abstract]   [Full Text] [Related]  

  • 6. Data monitoring committees and interim monitoring guidelines.
    Freidlin B; Korn EL; George SL
    Control Clin Trials; 1999 Oct; 20(5):395-407. PubMed ID: 10503800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized controlled trial of influenza vaccine in the elderly. Scientific scrutiny and ethical responsibility.
    Patriarca PA
    JAMA; 1994 Dec; 272(21):1700-1. PubMed ID: 7966901
    [No Abstract]   [Full Text] [Related]  

  • 8. Inefficacy interim monitoring procedures in randomized clinical trials: the need to report.
    Korn EL; Freidlin B
    Am J Bioeth; 2011 Mar; 11(3):2-10. PubMed ID: 21400374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Data monitoring committees and capturing relevant information of high quality.
    Fleming TR
    Stat Med; 1993 Mar; 12(5-6):565-70; discussion 571-3. PubMed ID: 8493432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is informed consent always necessary for randomized, controlled trials?
    Carome MA
    N Engl J Med; 1999 Aug; 341(6):448-9; author reply 450. PubMed ID: 10438260
    [No Abstract]   [Full Text] [Related]  

  • 11. Monitoring data and safety in the WHO Antenatal Care Trial.
    Bergsjø P; Bréart G; Morabia A
    Paediatr Perinat Epidemiol; 1998 Oct; 12 Suppl 2():156-64. PubMed ID: 9805728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Data monitoring committees, interim analysis and early termination in paediatric trials.
    Fernandes RM; van der Lee JH; Offringa M
    Acta Paediatr; 2011 Oct; 100(10):1386-92. PubMed ID: 21434998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is informed consent always necessary for randomized, controlled trials?
    Truog RD; Robinson W; Randolph A; Morris A
    N Engl J Med; 1999 Mar; 340(10):804-7. PubMed ID: 10072420
    [No Abstract]   [Full Text] [Related]  

  • 14. Stopping a trial early - and then what?
    Wittes J
    Clin Trials; 2012 Dec; 9(6):714-20. PubMed ID: 22879573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behind closed doors: the data monitoring board in randomized clinical trials.
    Wittes J
    Stat Med; 1993 Mar; 12(5-6):419-24. PubMed ID: 8493420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The importance of preservation of the ethical principle of equipoise in the design of clinical trials: relative impact of the methodological quality domains on the treatment effect in randomized controlled trials.
    Djulbegovic B; Cantor A; Clarke M
    Account Res; 2003; 10(4):301-15. PubMed ID: 14989285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethical issues in the design and conduct of randomised controlled trials.
    Edwards SJ; Lilford RJ; Braunholtz DA; Jackson JC; Hewison J; Thornton J
    Health Technol Assess; 1998 Dec; 2(15):i-vi, 1-132. PubMed ID: 10194615
    [No Abstract]   [Full Text] [Related]  

  • 18. Early stopping rules--clinical perspectives and ethical considerations.
    Baum M; Houghton J; Abrams K
    Stat Med; 1994 Jul 15-30; 13(13-14):1459-69; discussion 1471-2. PubMed ID: 7973225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Missing data in rheumatologic studies and the practical reality of modern approaches to the analysis of incomplete subject data: comment on the article by Baron et al and the editorial by Boers.
    Steele R; Hudson M
    Arthritis Rheum; 2008 Sep; 59(9):1367-8. PubMed ID: 18759312
    [No Abstract]   [Full Text] [Related]  

  • 20. ['Informed consent' and prerandomization].
    de Craen AJ
    Ned Tijdschr Geneeskd; 2000 Jul; 144(27):1301-3. PubMed ID: 10918907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.